SCHEMBL3955095

SCHEMBL3955095

Cc1onc(-c2ccccc2)c1C#Cc1ncc[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 5/20 0.44
PTGS2 P35354 5/20 0.44
MAPT P10636 2/20 0.42
GABRA5 P31644 3/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
GAA P10253 1/20 0.39
CA12 O43570 1/20 0.38
MT-CO2 P00403 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
LMNA P02545 1/20 0.38
CA3 P07451 1/20 0.38
ADRB2 P07550 1/20 0.38
ADRB1 P08588 1/20 0.38
CYP3A4 P08684 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
CHRM1 P11229 1/20 0.38
ADRA2B P18089 1/20 0.38
CA4 P22748 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3952333 0.79 PTGS1 (0.50) PTGS1PTGS2MAPTGABRA5KMT2A
SCHEMBL4083806 0.77 PTGS1 (0.45) PTGS1PTGS2MAPTGABRA5KMT2A
SCHEMBL3951876 0.77 GABRA5 (0.48) PTGS1PTGS2MAPTGABRA5KMT2A
SCHEMBL3952797 0.75 PTGS1 (0.45) PTGS1PTGS2MAPTGABRA5KMT2A
SCHEMBL3952892 0.74 PTGS1 (0.44) PTGS1PTGS2MAPTGABRA5KMT2A
SCHEMBL3951355 0.74 PTGS1 (0.44) PTGS1PTGS2MAPTGABRA5KMT2A
SCHEMBL3950863 0.74 PTGS1 (0.44) PTGS1PTGS2MAPTGABRA5KMT2A
SCHEMBL3952793 0.73 PTGS1 (0.46) PTGS1PTGS2MAPTGABRA5KMT2A
SCHEMBL3951095 0.73 PTGS1 (0.43) PTGS1PTGS2MAPTGABRA5KMT2A
SCHEMBL3950875 0.73 PTGS1 (0.43) PTGS1PTGS2MAPTGABRA5KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029559-B1 ARYL-4-ETHYNYL-ISOXAZOLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2009-08-05 EP claimed
US-7544704-B2 Aryl-4-ethynyl-isoxazole derivatives HOFFMANN-LA ROCHE INC. (US) 2009-06-09 US claimed
EP-2029559-A1 ARYL-4-ETHYNYL-ISOXAZOLE DERIVATIVES F. Hoffmann-Roche AG (CH) 2009-03-04 EP claimed
US-20070287739-A1 Aryl-4-ethynyl-isoxazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2007-12-13 US claimed
WO-2007137954-A1 ARYL-4-ETHYNYL-ISOXAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-12-06 WO claimed
EP-2029559-B1 ARYL-4-ETHYNYL-ISOXAZOLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2009-08-05 EP disclosed
US-7544704-B2 Aryl-4-ethynyl-isoxazole derivatives HOFFMANN-LA ROCHE INC. (US) 2009-06-09 US disclosed
EP-2029559-A1 ARYL-4-ETHYNYL-ISOXAZOLE DERIVATIVES F. Hoffmann-Roche AG (CH) 2009-03-04 EP disclosed
US-20070287739-A1 Aryl-4-ethynyl-isoxazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2007-12-13 US disclosed
WO-2007137954-A1 ARYL-4-ETHYNYL-ISOXAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-12-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287739-A1 Aryl-4-ethynyl-isoxazole derivatives GABRA5, GABRA4, GABRA1 PTGS1 2858/4885PTGS2 3774/4885MAPT 383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.